P

Inventor

KUFE DONALD W

US46 patents
⚠️ This page may combine multiple inventors who share the name “KUFE DONALD W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

19 patents
US5053489AOct 1, 1991

Genetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigen

DANA FARBER CANCER INST INC80 citations96
US4963484AOct 16, 1990

Genetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigen

DANA FARBER CANCER INST INC88 citations96
US7247297B2Jul 24, 2007

Use of DF3/MUC1 regulated expression in gene therapy

DANA FARBER CANCER INST INC30 citations92
US6420335B1Jul 16, 2002

Combination of radiotherapy and anti-angiogenic factors

DANA FARBER CANCER INST INC20 citations92
US7556935B2Jul 7, 2009

Induction of apoptosis by cellular stress

DANA FARBER CANCER INST INC9 citations84
US7041653B2May 9, 2006

Gene transcription and ionizing radiation: methods and compositions

DANA FARBER CANCER INST INC4 citations74
US11136410B2Oct 5, 2021

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

DANA FARBER CANCER INST INC2 citations72
US10059775B2Aug 28, 2018

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

DANA FARBER CANCER INST INC2 citations72
US9546201B2Jan 17, 2017

MUC-1 cytoplasmic domain peptides as inhibitors of cancer

DANA FARBER CANCER INST INC3 citations72
US8017315B2Sep 13, 2011

Mitochondrial localization of MUC1

DANA FARBER CANCER INST INC2 citations63
US12466895B2Nov 11, 2025

Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)

DANA FARBER CANCER INST INC0 citations62
US10617773B2Apr 14, 2020

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

DANA FARBER CANCER INST INC1 citations62
US8012695B2Sep 6, 2011

Methods and compositions relating to promoter regulation by MUC1 and KLF proteins

DANA FARBER CANCER INST INC0 citations52
US7972870B2Jul 5, 2011

Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3

DANA FARBER CANCER INST INC0 citations52
US7931904B2Apr 26, 2011

Modulation of MUC1 activity

DANA FARBER CANCER INST INC1 citations52
US7871784B2Jan 18, 2011

Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins

DANA FARBER CANCER INST INC0 citations52
US9789156B2Oct 17, 2017

Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer therapy using mucin 1 (MUC1) peptides and hemotherapeutics

DANA FARBER CANCER INST INC0 citations51
US9572855B2Feb 21, 2017

Combination anti-estrogen receptor cancer therapy using MUC1 peptides and chemotherapeutics

DANA FARBER CANCER INST INC0 citations51
US9096687B2Aug 4, 2015

Inhibition of inflammation using antagonists of MUC1

DANA FARBER CANCER INST INC1 citations51

ARCH DEV CORP

8 patents

KUFE DONALD W

8 patents

UNIV CHICAGO

4 patents

(unassigned)

1 patent

AMIRA INC

1 patent

DANA FARBER CANCER INC

1 patent

ILEX ONCOLOGY INC

1 patent

DANA FARBER CANCER INSITUTE IN

1 patent

KHARBANDA SURENDER

1 patent

SPECTOR THOMAS

1 patent